NCT01733355View on ClinicalTrials.gov

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Alzheimers DiseaseAD
Interventions
RADIATION

[F18] T807

Dose for normal volunteer undergoing dosimetry evaluation will not exceed 20 mCi, dose for high probability of Alzheimer's and low probability Alzheimer's undergoing brain imaging only will not exceed 10 mCi

Trial Locations (2)

90033

Research Site, Los Angeles

92697

Research Site, Irvine

Sponsors
All Listed Sponsors
lead

Avid Radiopharmaceuticals

INDUSTRY